Related Experiment Video
Updated: Feb 27, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
Interventions to slow cardiovascular aging: Dietary restriction, drugs and novel molecules
Christian Heiss1, Ioakim Spyridopoulos2, Judith Haendeler3
1Division of Cardiology, Pulmonology and Vascular Medicine, Medical Faculty, University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany.
Insights
Cardiovascular aging can be modulated by dietary and pharmacologic interventions. Research explores plant bioactives and lifestyle changes to improve vascular health and potentially extend lifespan.
Area of Science:
- Gerontology
- Cardiovascular Medicine
- Nutritional Science
Background:
- Cardiovascular aging involves dynamic changes in function and structure.
- These age-dependent vascular changes remain modifiable in older adults.
- Interventions targeting specific signaling pathways show promise.
Purpose of the Study:
- To review current approaches for improving age-dependent vascular changes.
- To explore the role of dietary restriction and pharmacologic agents.
- To assess the potential of nutritional strategies and plant bioactives.
Main Methods:
- Review of literature on cardiovascular aging interventions.
- Analysis of signaling pathways (TOR, GH/IGF-1, AMPK, sirtuins).
- Evaluation of dietary approaches (Mediterranean diet, bioactives like flavanols, anthocyanins, lignins).
Main Results:
- Dietary restriction and pharmacologic agents can modulate vascular aging.
- Plant bioactives show potential in improving endothelial function, arterial stiffness, blood pressure, cholesterol, and glycemic control.
- Mechanisms of action for many bioactives are not fully understood.
Conclusions:
- Interventions targeting signaling pathways and nutritional approaches show promise for vascular healthy aging.
- Further research is needed to elucidate the mechanisms of action of plant bioactives.
- Determining if these interventions can reverse cardiovascular aging and increase healthspan/longevity in humans requires investigation.
Abstract:
Cardiovascular aging is a highly dynamic process. Despite the fact that cardiovascular function and structure change with age, they can still be modulated even in aged humans. The most prominent approaches to improve age-dependent vascular changes include dietary restriction and pharmacologic agents interacting with signaling pathways implicated in this context. These include inhibition of TOR, glycolysis, and GH/IGF-1, activation of sirtuins, and AMPK, as well as modulators of inflammation, epigenetic pathways, and telomeres. Promising nutritional approaches include Mediterranean diet and novel dietary bioactives including flavanols, anthocyanins, and lignins. Many plant bioactives improve cardiovascular parameters implied in vascular healthy aging including endothelial function, arterial stiffness, blood pressure, cholesterol, and glycemic control. However, the mechanism of action of most bioactives is not established and it remains to be elucidated whether they act as dietary restriction mimetics or via other modes of action. Even more importantly, whether these interventions can slow or even reverses components of cardiovascular aging itself and can increase healthspan or longevity in humans needs to be determined.
More Related Videos
10:39A Suppressor Screen for the Characterization of Genetic Links Regulating Chronological Lifespan in Saccharomyces cerevisiae
Published on: September 17, 2020
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
Related Concept Videos
Atherosclerosis III: Management
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cardiovascular Drugs: Classification based on Therapeutic Indications
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications
Heart Failure V: Medical Management